Stockreport

ImmunityBio (IBRX) Soars 137% on Expansion Plan, Clinical Results [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF ImmunityBio skyrocketed by 137 percent week-on-week to hit a new record high after rallying for 11 consecutive days, thanks to a flurry of catalysts, including a whoppi [Read more]